ENTITY
GlaxoSmithKline PLC

GlaxoSmithKline PLC (GSK LN)

105
Analysis
Health CareUnited Kingdom
GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
Refresh
bullishSosei Group
26 Sep 2018 21:03

Investment Thesis and Valuation

Key Drivers Royalty from Seebri / Ultibro and QVM149 (expected launch in FY20e) to peak at ¥ 4.86b in FY25e Majority of the potential milestones...

bullishShionogi & Co
22 Jun 2018 18:30

Innovation to Help Maintain HIV Franchise Market Share and Weather Harsh Domestic Market Conditions

Continuous innovation at HIV Franchise to not only help defend market share…. Concerns about competition from Gilead Sciences Inc (GILD US)'s,...

21 Jun 2018 14:15

Sector Capsule: Oral Care in Taiwan

Oral care increased by 3% in current value during 2017, with sales reaching TWD7.6 billion. The ageing population increased the awareness of and...

Share
12 Apr 2018 23:44

A Conversation with Biogen

Biogen Inc (BIIB US) is Samsung Biologics Co., Ltd (207940 KS) 's minority (5.4%) partner in the Samsung Bioepis JV that manufactures and sells...

Share
16 Mar 2018 10:27

Sector Capsule: Other Hot Drinks in Singapore

Other Hot Drinks retail sales declined by 1% to SGD66 million, and marginally in volume terms to 7,366 tonnes in 2017 Consumer fatigue in the...

Share
x